TEMIR YETISHMOVCHILIGI ORQALI KECHADIGAN ANEMIYANI ERTA DIAGNOSTIKASI VA DAVOLASHNI OPTIMALLASHTIRISH
Keywords:
temir yetishmovchiligi anemiyasi, ferritin, erta diagnostika, parenteral temir, og‘iz orqali temir, gemoglobin, MCV, MCHAbstract
Mazkur tadqiqot temir yetishmovchiligi orqali kechadigan anemiyani erta aniqlashda laborator ko‘rsatkichlarning, xususan ferritin darajasining diagnostik ahamiyatini baholash hamda turli temir preparatlari bilan davolash samaradorligini qiyosiy tahlil qilishga bag‘ishlangan. Tadqiqotga 72 nafar temir yetishmovchiligi anemiyasi tashxisi qo‘yilgan bemor kiritildi. Bemorlar parenteral va og‘iz orqali temir preparatlari bilan davolangan ikki guruhga ajratildi. Natijalar ferritin darajasining gemoglobinga nisbatan temir yetishmovchiligini erta aniqlashda yuqori sezgirlikka ega ekanligini ko‘rsatdi. Parenteral temir preparatlari gematologik ko‘rsatkichlarni tezroq tiklab, klinik simptomlarning erta regressiyasini ta’minladi. Ferritinga asoslangan erta diagnostika va individual davolash yondashuvi temir yetishmovchiligi anemiyasini samarali boshqarishda muhim ahamiyatga ega.
References
1.World Health Organization.
2.Iron Deficiency Anaemia: Assessment, Prevention and Control. Geneva: WHO; 2001.
3.World Health Organization.
4.Serum Ferritin Concentrations for the Assessment of Iron Status in Individuals and Populations. Geneva: WHO; 2011.
5.British Society for Haematology.
6.Guidelines on the diagnosis and management of iron deficiency anaemia. Br J Haematol. 2021;193(2): 245–259.
7.European Hematology Association.
8.Management of iron deficiency in adults. Hematologica. 2018;103(6): 1–10.
9.Ganz T, Nemeth E.
10.Iron homeostasis in host defence and inflammation. The Lancet. 2015;386(9997): 104–114.
11.Van Wyck DB, Mangione A, Morrison J, et al.
12.Safety and efficacy of ferric carboxymaltose in patients with iron deficiency anemia. American Journal of Hematology. 2009;84(10): 579–585.